X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Current Pharmaceutical Analysis

期刊標題檢索 CURR PHARM ANAL 最新評論: I also want to know (2023-12-06)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Current Pharmaceutical Analysis]您好,您是該頁面的第 23282 位訪客。

期刊簡介
期刊名稱Current Pharmaceutical Analysis Current Pharmaceutical Analysis
LetPub Score
5.1
51 ratings
Rate

Reputation
6.1

Influence
3.6

Speed
8.4

期刊簡稱CURR PHARM ANAL
ISSN1573-4129
E-ISSN1875-676X
h-index22
CiteScore
CiteScoreSJRSNIPCiteScore Rank
1.500.1840.253
Subject fieldQuartilesRankPercentile
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Pharmaceutical Science
Q3115 / 183
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Biophysics
Q4124 / 152
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Biochemistry
Q4371 / 438
Category: Pharmacology, Toxicology and Pharmaceutics
Subcategory: Molecular Medicine
Q4156 / 178

自引率 (2023-2024)14.30%自引率趨勢
掲載範囲
Aims & Scope

Current Pharmaceutical Analysis publishes expert reviews and original research articles on all the most recent advances in pharmaceutical and biomedical analysis. All aspects of the field are represented including drug analysis, analytical methodology and instrumentation. The journal is essential to all involved in pharmaceutical, biochemical and clinical analysis.
官方網站http://benthamscience.com/journal/index.php?journalID=cpa
在線稿件提交http://benthamscience.com/journal/authors-guidelines.php?journalID=cpa#top
開放訪問No
出版商Bentham Science Publishers B.V.
主題領域医学
出版國/地區U ARAB EMIRATES
發行頻率四半期刊行
創刊年2005
每年文章數60每年文章數趨勢
黃金OA百分比1.45%
Web of Science 四分位
2023-2024
WOS Quartile: Q4

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ4317/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1573-4129%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 2 Month(s)
競爭力 *來自作者的數據: About 50%
參考鏈接
相關期刊 【Current Pharmaceutical Analysis】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    PHARMACOLOGICAL REVIEWSH-index: 210

    CiteScore: 34.70
    DRUG RESISTANCE UPDATESH-index: 100

    CiteScore: 26.20
    ADVANCED DRUG DELIVERY REVIEWSH-index: 278

    CiteScore: 28.10
    TRENDS IN PHARMACOLOGICAL SCIENCESH-index: 201

    CiteScore: 23.90
    PHARMACOLOGY & THERAPEUTICSH-index: 180

    CiteScore: 23.00
    MEDICINAL RESEARCH REVIEWSH-index: 119

    CiteScore: 29.30
    PHARMACOLOGICAL RESEARCHH-index: 118

    CiteScore: 18.70
    ARCHIVES OF PHARMACAL RESEARCHH-index: 75

    CiteScore: 13.40
    BIOMEDICINE & PHARMACOTHERAPYH-index: 78

    CiteScore: 11.90
    BRITISH JOURNAL OF PHARMACOLOGYH-index: 190

    CiteScore: 15.40
    學科內最受檢索的期刊 頁面查看次數
    BIOMEDICINE & PHARMACOTHERAPY498363
    PHYTOMEDICINE340440
    LIFE SCIENCES285957
    International Journal of Pharmaceutics242458
    PHARMACOLOGICAL RESEARCH241410
    European Journal of Pharmacology204273
    BIOCHEMICAL PHARMACOLOGY202715
    JOURNAL OF NATURAL PRODUCTS196707
    BRITISH JOURNAL OF PHARMACOLOGY165166
    MOLECULAR PHARMACEUTICS162843
  •  

    Current Pharmaceutical Analysis Current Pharmaceutical Analysis
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Current Pharmaceutical Analysis] 的評論撰寫評論
作者: 蒙德瑜敏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2023-12-06 13:06:05 評論於
I also want to know
(0) 讚! | 蒙德瑜敏

作者: 张


領域: 医学
審稿時間: 3.0 month(s)
結果: 修改後接受


撰寫評論

2022-11-18 14:51:26 評論於
The third article on mass spectrometry analysis of peptide structures. It was submitted in February 2022 and officially published in November, which is considered relatively fast. Unfortunately, it is a paid article.
(0) 讚! | 张

作者: zero


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-07-05 21:48:02 評論於
May I ask if the review process is fast? Do I need to pay for the publication?
(0) 讚! | zero

作者: 依巧酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-02-16 17:29:51 評論於
Hello, I would like to ask if the manuscript submitted last year will be accepted?
(0) 讚! | 依巧酱大魔王

作者: 姝美小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-08 22:00:34 評論於
Both are needed
(0) 讚! | 姝美小公主

作者: 如寒公子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-15 21:37:56 評論於
Do we still need to pay publishing fees if this magazine does not choose OA?
(0) 讚! | 如寒公子

作者: 困困


領域: 医学
審稿時間: 3.0 month(s)
結果: 待定&不明


撰寫評論

2021-06-02 17:09:00 評論於
Excuse me, does this magazine require a layout fee?
(0) 讚! | 困困

作者: 姝美小公主


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-04-17 13:57:47 評論於
Review Speed: 3.0 | Submission Hit Rate: 75.0 | Page Fee: 3500.0
Emphasized Research Direction: Drug Analysis
Experience sharing: Due to the impact of the epidemic and initially unclear image quality, the review process was slow. Submitted on August 24, 2020, reviewed on December 12, 2020, revised on December 26, 2020, accepted on February 14, 2021, and proofed on April 15, 2021
(0) 讚! | 姝美小公主

作者: 张


領域: 医学
審稿時間: 5.0 month(s)
結果: 修改後接受


撰寫評論

2020-12-14 12:04:32 評論於
It is an article on the discovery and structure identification of new drug impurities. The paper was submitted at the end of June 2020, and the minor revision was required on September 7th. The language was modified. After it was resubmitted, the DOI was assigned in early December, which was quite fast. Page numbering will be slower to be assigned, and it is scheduled for next year.

(0) 讚! | 张

作者: 辉夜碧秋


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-08-03 22:26:13 評論於
Do you accept meta-analysis?
(0) 讚! | 辉夜碧秋

作者: 极乐琇晶


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-12-03 13:33:24 評論於
How to review and provide feedback on this magazine
(0) 讚! | 极乐琇晶

作者: 极乐琇晶


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-12-03 10:40:14 評論於
How to view and make edits to this magazine?
(0) 讚! | 极乐琇晶

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-14 08:19:30 評論於
Anyway, with this bearish trend, there is unlikely to be any change. As long as it doesn't fall, that would be fortunate
(0) 讚! | 凌霄高洁

作者: 东海冷丝


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-12-01 16:08:05 評論於
Review speed: 3.0 | Submission hit rate: 50.0
Sharing Experience: My submission has been in for over 2 months, and the status hasn't changed at all. It's frustrating
(0) 讚! | 东海冷丝

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2014-07-03 18:24:30 評論於
Review Speed: 1.0
Experience Sharing: The article I submitted was reviewed within two weeks, revised within a week, and accepted a few days after revision. The speed is quite fast
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-09-26 16:53:05 評論於
Review speed: 2.0 | Submission acceptance rate: 50.0
Experience sharing: The articles I submitted took about one and a half months to be reviewed, and it took 5 months to be formally published. I feel that it is quite fast and the editors are very responsible
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Current Pharmaceutical Analysis] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*